Drugs / CD133+ cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00765050 | Jan 2009 → Oct 2012 | — | PETHEMA Foundation | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD133+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00765050 ↗ |
| Route | Intramuscular | “intramuscular administration of CD133+ cells” NCT00765050 ↗ |